REDWOOD SHORES, CA--(Marketwire - March 29, 2010) -
Oracle (NASDAQ: ORCL
- Keyrus Biopharma, a contract research organization operating in
Europe and part of the Keyrus Group, has standardized on Oracle® Clinical and Oracle
Database to help increase efficiency in clinical trial data collection,
improve data quality and security, and support the organization's European
- With Oracle Clinical, Keyrus Biopharma has gained greater flexibility
in designing clinical trials and managing data collection, as well as
increased scalability to support business expansion.
- The solution provides comprehensive data validation capabilities --
through a library of reusable procedures based on Clinical Data Acquisition
Standards Harmonization (CDash) and Clinical Data Interchange Standards
Consortium (CDISC) Study Data Tabulation Model (SDTM) standards -- that
help Keyrus Biopharma to improve the efficiency of data collection and
validation, and reduce the time to database lock.
- Keyrus Biopharma is streamlining compliance and increasing security
with Oracle Clinical's robust audit trail capabilities and support for 21
CFR Part 11.
- Oracle's strength and stability as a leading provider of IT solutions
for the health sciences sector and Oracle Clinical's broad functionality
were key factors in Keyrus Biopharma's selection process.
- Keyrus Biopharma worked with Pharmasol, an Oracle Gold Partner, and
RapidLive -- an Oracle Accelerate solution that provides ready-to-use
implementations of Oracle Health Sciences applications -- to accelerate the
- "As a mid-size organization, we needed a reliable, but
easy-to-implement clinical data management system. With Oracle Clinical,
which we implemented using Pharmasol's RapidLive methodology, we are now
equipped to deliver clinical trials with greater confidence and efficiency
while streamlining compliance," said Olivier Perrot, Head of Data
Management, Keyrus Biopharma.
- "Rapidly growing contract research organizations, like Keyrus
Biopharma, require flexible and scalable health sciences applications that
help them to accelerate the clinical trial process while navigating an
increasingly complex regulatory environment. Oracle Clinical answers this
call with unmatched functionality, scalability, and built-in compliance
derived from Oracle's experience with hundreds of companies that have
conducted clinical trials," said Neil de Crescenzo, Senior Vice President
and General Manager, Oracle Health Sciences.
About Keyrus Biopharma
As a Contract Research Organization (CRO) and major player in clinical
research, Keyrus Biopharma has been assisting the pharmaceutical industry
for over 12 years in the development of their drugs. Today, Keyrus
Biopharma provides expertise and consultancy in all clinical research areas
on the basis of this experience and has adapted to the requirements of new
environments / areas such as nutrition, biotechnology, cosmetology and
medical devices. Keyrus Biopharma employs over 150 associates and is
located in France and Belgium (Paris, Nantes and Brussels). More
information at www.keyrusbiopharma.com.
Oracle (NASDAQ: ORCL) is the world's most complete, open, and integrated
business software and hardware systems company. For more information about
Oracle, visit oracle.com.
Oracle and Java are registered trademarks of Oracle and/or its affiliates.
Other names may be trademarks of their respective owners.